Novel Human Umbilical Di-Chimeric (HUDC) cell therapy for transplantation without life-long immunosuppression

BACKGROUND: Cell-based therapies are promising for tolerance induction in bone marrow (BM), solid organs, and vascularized composite allotransplantation (VCA). The toxicity of bone marrow transplantation (BMT) protocols precludes this approach from routine clinical applications. To address this prob...

Descripción completa

Detalles Bibliográficos
Autores principales: Siemionow, Maria, Cwykiel, Joanna, Chambily, Lucile, Gacek, Stephanie, Brodowska, Sonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442563/
https://www.ncbi.nlm.nih.gov/pubmed/37614644
http://dx.doi.org/10.21037/sci-2023-024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442563/
https://www.ncbi.nlm.nih.gov/pubmed/37614644
http://dx.doi.org/10.21037/sci-2023-024

Ejemplares similares